Table 1. Baseline characteristics according to urinary albumin levels during the (a) 2-year or (b) 3-year baseline period.
| Normo albuminuria |
Micro albuminuria |
Macro albuminuria |
All participants |
|
|---|---|---|---|---|
| (a) 2-year baseline period (n = 1868) | ||||
| N | 1078 | 495 | 295 | 1868 |
| Age (years; mean [SD]) | 60 (11.3) | 62 (11.3) | 59 (11.8) | 60 (11.4) |
| Men (n [%]) | 578 (53.6) | 300 (60.6) | 192 (65.1) | 1070 (57.3) |
| UACR (mg/g; median [IQR]) | 11 (7, 17) | 72 (46, 135) | 1002 (533, 2378) | 20 (10, 109) |
| eGFR (mL/min/1.73 m2; mean [SD]) | 82 (22.5) | 76 (24.2) | 57 (24.9) | 77 (24.9) |
| Systolic BP (mmHg; mean [SD]) | 129 (18.2) | 137 (19.8) | 143 (20.8) | 133 (19.7) |
| Diastolic BP (mmHg; mean [SD]) | 76 (29.8) | 77 (11.4) | 78 (13.0) | 76 (24.0) |
| History of CVD (n [%]) | 101 (9.4) | 56 (11.3) | 32 (10.9) | 189 (10.1) |
| HbA1c (%; mean [SD]) | 8.0 (1.8) | 8.2 (1.8) | 8.1 (1.8) | 8.0 (1.8) |
| (b) 3-year baseline period (n = 2001) | ||||
| N | 1209 | 525 | 267 | 2001 |
| Age (years; mean [SD]) | 60 (11.2) | 61 (11.1) | 59 (11.6) | 60 (11.2) |
| Men (n [%]) | 671 (55.5) | 315 (60.0) | 173 (64.8) | 1159 (57.9) |
| UACR (mg/g; median [IQR]) | 11 (7, 17) | 70 (46, 127) | 830 (497, 2038) | 19 (9, 79) |
| eGFR (mL/min/1.73 m2; mean [SD]) | 82 (22.4) | 77 (24.5) | 60 (24.6) | 77 (24.3) |
| Systolic BP (mmHg; mean [SD]) | 128 (17.6) | 137 (19.2) | 143 (20.7) | 133 (19.3) |
| Diastolic BP (mmHg; mean [SD]) | 75 (28.4) | 76 (11.6) | 79 (12.5) | 76 (23.3) |
| History of CVD (n [%]) | 104 (8.6) | 54 (10.3) | 26 (9.7) | 184 (9.2) |
| HbA1c (%; mean [SD]) | 7.8 (1.8) | 8.0 (1.7) | 8.0 (1.7) | 7.9 (1.8) |
UACR, urine albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; BP, blood pressure; CVD, cardiovascular disease; SD, standard deviation; IQR, interquartile range.